Category Archives: News

Adventist Health System Expands Partnership with Premier Inc. to Better Treat Diseases

By | News | No Comments

Florida-based health system to employ PremierConnect® pharmacy clinical surveillance and analytics across 40 hospitals to enhance medication management, antibiotic stewardship

CHARLOTTE, N.C. (March 9, 2017) — Adventist Health System, a faith-based healthcare organization headquartered in Altamonte Springs, Florida, has expanded its partnership with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, to use pharmacy clinical surveillance and analytics in its effort to better treat diseases.

A member of Premier for more than 20 years, Adventist Health System uses clinical, operational and supply chain analytics in the PremierConnect® performance improvement platform. By expanding its partnership in 40 hospitals across nine states, Adventist Health System will integrate Premier’s pharmacy clinical surveillance and analytics with existing PremierConnect analytics to enhance medication management and antibiotic stewardship.

“Patient safety has always been a top priority at Adventist Health System,” said Loran D. Hauck, MD, chief clinical officer for Adventist Health System. “Premier’s pharmacy clinical surveillance and analytics solution will help our pharmacists forecast and identify opportunity areas, prioritize next steps, document interventions and benchmark progress across the continuum. This is particularly important as we enhance our antimicrobial stewardship program with capabilities to quickly identify situations where antibiotics have no clinical benefit and reduce the emergence of antibiotic resistance.”

PremierConnect pharmacy clinical surveillance and analytics, powered by TheraDoc®, streamline data for pharmacists to target clinical intervention opportunities, track performance with customizable departmental reports and alerts, and optimize drug therapies in real-time. Providers use the solution to create or enhance antimicrobial stewardship programs by identifying cases of antibiotic overuse, reducing time-to-appropriate therapy and enhancing treatments for difficult-to-treat pathogens. Additionally, the solution helps providers adhere to the Centers for Disease Control and Prevention’s National Healthcare Safety Network reporting requirements.

“Adventist Health System is a leading organization that is committed to fostering an environment where patient safety and the efficacious use of life-saving drug therapies is a top priority,” said Leigh Anderson, chief information officer, Premier. “We’re thrilled they chose to build on their relationship with Premier to improve disease treatments and reduce the administrative burden on pharmacists whose time is better spent focusing on delivering safe and effective care.”

The financial terms of the agreement were not disclosed, and are not expected to materially affect Premier’s fiscal 2017 financial results.

About Premier Inc.

Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provider organizations. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.

Forward-looking statements

Matters discussed in this release that are not statements of historical or current facts, such as  Adventist Health System’s anticipated use of Premier’s performance services at expected levels, as discussed herein, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to Premier’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside Premier’s control. More information on potential factors that could affect Premier’s financial results is included from time to time in the “Forward Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Premier’s periodic and current filings with the SEC and available on Premier’s website at investors.premierinc.com. Forward looking statements speak only as of the date they are made. Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date

https://www.premierinc.com/adventist-health-system-expands-partnership-premier-inc-better-treat-diseases/

Morgan Rae Guthrie

Director, Public Relations

Premier Inc.

P: 704.816.4152; C: 704.425.3056

13034 Ballantyne Corporate Place Charlotte, NC 28277

Today, an urgently needed tool was introduced to help US hospitals implement strategies to promote the appropriate, safe use of antibiotics.

By | News | No Comments

Today, an urgently needed tool was introduced to help US hospitals implement strategies to promote the appropriate, safe use of antibiotics. The National Quality Forum (NQF) and the Centers for Disease Control and Prevention (CDC), alongside a team of more than 25 experts, including Premier Inc., convened to create the Antibiotic Stewardship in Acute Care: A Practical Playbook.

Examples of strategies in the Playbook include team-wide, systematic approaches to: assessing when patients need antibiotics and when treatment should be adjusted; educating staff, family, and patients about appropriate antibiotic use; and, tracking and reporting antibiotic prescribing, use, and resistance.

Premier hospital members have been taking steps to combat antibiotic-resistant bacteria. In fact, since the launch of Premier’s nationwide collaborative initiative to improve antibiotic overuse, more hospitals are adopting antibiotic stewardship programs. Premier’s spring Economic Outlook survey suggests 97 percent of health system C-Suite feel that developing/enhancing an antimicrobial stewardship program is a top priority – this is up from 81 percent in the fall.

It has been estimated that up to half of antibiotic use in hospitals is unnecessary and inappropriate. In fact, Premier/CDC research found that 78% of hospitals were overprescribing redundant combinations of intravenous (IV) antibiotics for two or more days. In addition, antibiotic overuse and misuse have spurred the spread of Clostridium difficile infections that can cause life-threatening colitis. In a recent study on the impact of C.difficile, Premier found that the majority of cases analyzed were associated with concomitant antibiotic use.

Premier with its members are committed to reducing HAIs, including those acquired due to antibiotic resistance. To join NQF’s webinar at 1:30 p.m. ET today to launch the Playbook, click here.

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

By | News | No Comments

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions.

TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier’s board of directors unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117 million represents a purchase price multiple in the 10-11 times range.

Read More

Article in Infection Control and Hospital Epidemiology concludes TheraDoc alerting combined with antimicrobial stewardship intervention has multiple postive effects

By | News | No Comments

The article illustrates how TheraDoc’s active alerting was used in combination with antimicrobial stewardship interventions on patients with gram-negative bacteremia. The study discussed in this article was a quasi-experimental retrospective cohort study conducted at three hospitals within Detroit Medical Center, with a combined 1,100 beds. Data resulting from active alerting of a positive blood culture coupled with stewardship intervention was compiled during 2010–2011 and compared to data from patients who received no formalized stewardship intervention during 2009.

Read More

Hospira’s TheraDoc™ Infection Control Assistant Ranked #1 In Its Category In The Latest “Best In KLAS” Report

By | News | No Comments

LAKE FOREST, Ill., Jan. 23, 2013 – Hospira (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced that its TheraDoc™ Infection Control Assistant™ has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2012: Software and Services Report (more information available at www.theradoc.com). The full report is available at www.KLASresearch.com. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

TheraDoc Infection Control Assistant scored the highest overall performance rating in KLAS’ Infection Control & Monitoring market segment, demonstrating excellence and leadership in serving customers and meeting their expectations. TheraDoc also received the highest product quality rating in its category, and the highest customer willingness to repurchase the software again (95 percent).[1]

“Hospira is honored that TheraDoc has been recognized for excellence in infection monitoring and surveillance software,” said France Pitera, vice president, Clinical Information Technology, Hospira. “This recognition is very meaningful since it comes as a direct result of feedback from TheraDoc users. This close working relationship with our users is one key reason why 100 percent of the more than 600 hospitals and healthcare facilities nationwide that have acquired TheraDoc still retain the system today.*”

The TheraDoc clinical surveillance system helps infection preventionists tackle many of their most significant challenges, including time spent on regulatory reporting, time to identification of healthcare-associated infections (HAIs), time to isolation of patients with infectious diseases, and tracking of organism resistance.

“After a thorough review of available systems, we chose TheraDoc to support our Infection Prevention program,” says Peggy Thompson, R.N., B.S.N., C.I.C., director of Infection Prevention at Tampa General Hospital. “It has proven to be an invaluable tool in the ever-changing world of infections and regulatory requirements. TheraDoc staff is receptive and incorporates changes based on feedback from their customers.”

The TheraDoc Infection Control Assistant provides infection preventionists with real-time (a matter of seconds) information needed to make a valid identification of infections, while leaving final determination in the hands of infection preventionists. The Infection Control Assistant also delivers powerful tools enabling infection preventionists to configure workflow to their unique needs, develop their own alerts, select from a large library of existing alerts, and automate creation of reports for the National Healthcare Safety Network.

As part of a suite of knowledge modules that make critical patient information and medical knowledge readily available, the Infection Control Assistant is designed to help clinicians intervene quickly, prescribe appropriately, and improve the quality and safety of patient care.[2],[3] The TheraDoc Clinical Intelligence™ Platform is the engine that powers these software modules, which also include the Antibiotic Assistant™, ADE Assistant™, Clinical Alerts Assistant™ and Anticoagulation Assistant™. For more information, visit www.theradoc.com.

KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS’ mission is to improve delivery by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4,500 hospitals and more than 2,500 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors.

About Hospira

Hospira, Inc., is the world’s leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

###

Media
Barbara Sullivan

Sullivan & Associates
(714) 374-6174Tareta Adams
Hospira
(224) 212-2535
Financial Community
Karen King

Hospira
(224) 212-2711Ruth Venning
Hospira
(224) 212-2774

[1] “Best in KLAS Awards 2012: Software and Services Report,” December 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.

[2] Hellinger W, Alvarez S, Brumble L, Keating M, Mendez J, Darracott R, Young E, Smith R, Mentel J. Optimizing antibiotic therapy with computerized integration of hospital information systems and an antibiotic management team (AMT). Poster session presented at: 42nd Annual Meeting of the Infectious Diseases Society of America; 2004 Sep 30-Oct 3; Boston, MA.

[3] Pass M, Song X, Mackie K, Perl T. Enhanced Isolation Practices To Improve Patient Safety: Preventing Nosocomial Transmission in a Hospital. Am J Infect Control. 2006 June;34(5):E105-E106.